2013 American Transplant Congress
Nucleoside Reverse Transcriptase Inhibitors without HBIG Can Be Safely and Cost-Effectively Administered To Prevent Recurrent Hepatitis B Viremia Post-Liver Transplant
Division of Transplantation, New York University School of Medicine, New York, NY
Background: Hepatitis B virus (HBV)-related cirrhosis and malignancy are common indications for orthotopic liver transplantation (OLT) worldwide. Hepatitis B immunoglobulin (HBIG) infusions are widely used…2013 American Transplant Congress
Growth Differentiation Factor 15 (GDF-15) Is Related to Anemia and Iron Metabolism in Heart Allograft Recipients
Anemia is more prevalent in heartl transplant recipients than in GFR-matched CKD patients, due to the combination of additional factors. Growth differentiation factor 15 (GDF-15)…2013 American Transplant Congress
Role of Mannose Binding Lectin on the Incidence of Rejection after Kidney and Other Solid Organ Transplantation
CHUV Transplantation Centre, Lausanne, Switzerland; CHUV Infectious Diseases, Lausanne, Switzerland
Background. The lectin pathway of complement activation and its major recognition molecule mannose binding lectin (MBL) may play an important role in immune damages after…2013 American Transplant Congress
Comparison of Patient and Graft Outcomes of HUS Kidney Transplants (KT) with and without Post Transplant Recurrence: A 10 Year Retrospective Analysis
Univ of Florida, Gainesville, FL
Purpose: Our study aimed to determine the difference in patient and graft outcomes between HUS Kidney Transplant Recipients (HUSKTR) with and without disease recurrence after…2013 American Transplant Congress
Is Mycophenolic Acid AUC a Good Pronostic Factor for BK Viremia?
Background: BK virus can induce severe impairment of graft function after kidney transplantation. Many studies have evaluated the best strategy to prevent BK-induced interstitial nephritis.…2013 American Transplant Congress
Cardiac Improvement Is Even Better in Diabetic End-Stage Renal Patients after Kidney Transplantation
Transplant Center, Acibadem University, Istanbul, Turkey
Cardiac disorders are very common in individuals with chronic kidney disease and are associated with high morbidity and mortality. The purpose of this study was…2013 American Transplant Congress
Concurrent Silencing of TLR and Kinase Signaling Pathways To Prevent Allograft Rejection in Heart Transplantation
Background: Toll-like receptors (TLRs) act as initiators and conductors responsible for both innate and adaptive immune responses in transplantation. The mammalian target of rapamycin (mTOR)…2013 American Transplant Congress
You Are What You Eat: Impact of Early Metabolic Syndrome on Long-Term Outcome after Heart Transplantation
BackroundMetabolic syndrome (MS) is seen in a high rate of heart transplant patients. In recent studies MS has been associated with long-term complications. The aim…2013 American Transplant Congress
Old DCD Kidneys to Old Recipients Have a Good Outcome; Is That the Solution for the Old Patients on the Waiting List?
Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom
The proportion of DCD donors among deceased transplants in UK has increased from 8% to 40 % with a striking increase in the mean age…2013 American Transplant Congress
T Cell Help Is Critical in Determining Mode of Alloantibody-Mediated Allograft Rejection
Department of Surgery, University of Cambridge, Cambridge, United Kingdom
INTRODUCTION. What determines whether alloantibody mediates acute or chronic allograft rejection remains unclear; here we examine the role of CD4 T cell help.METHODS. BALB/c hearts…
- « Previous Page
- 1
- …
- 64
- 65
- 66
- 67
- 68
- …
- 178
- Next Page »